| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -170,925 | -116,515 |
| Advances from related parties | 174,772 | 116,065 |
| Net cash provided by financing activities | 174,772 | 116,065 |
| Net change in cash | 3,847 | -450 |
| Cash and cash equivalents at beginning of period | 476 | - |
| Cash and cash equivalents at end of period | 4,323 | - |
ACRO BIOMEDICAL CO., LTD. (ACBM)
ACRO BIOMEDICAL CO., LTD. (ACBM)